MedTrace Logo

Early-Onset Colorectal Cancer Recurrence

NCT06271980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2024-03-12

No results posted yet for this study

Summary

Survivors of early-onset colorectal cancer (diagnosed before age 50) may experience colorectal cancer recurrence several years after curative-intent treatments, but clinical guidelines provide unclear guidance on endoscopic surveillance.

This study aims to predict recurrence-free survival and overall survival, in survivors of early-onset colorectal cancer, using a tumor-based molecular assay based on microRNA (ribonucleic acid)

Conditions

  • Colorectal Cancer Recurrent
  • Colorectal Cancer
  • Colorectal Neoplasms
  • Colorectal Adenocarcinoma
  • Colorectal Cancer Stage I
  • Colorectal Cancer Stage II
  • Colorectal Cancer Stage III

Interventions

OTHER

ENCORE

A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.

Sponsors & Collaborators

  • IRCCS San Raffaele

    collaborator OTHER

  • Institute of Biomedical Research of Salamanca, Salamanca, Spain

    collaborator UNKNOWN

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Ajay Goel, PhD · City of Hope Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06271980 on ClinicalTrials.gov